Ensign Peak Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Sell
10,362
-1,000
-9% -$22.9K ﹤0.01% 1356
2026
Q1
$250K Hold
11,362
﹤0.01% 1205
2025
Q4
$134K Sell
11,362
-26,450
-70% -$340K ﹤0.01% 1474
2025
Q3
$599K Sell
37,812
-9,450
-20% -$137K ﹤0.01% 1309
2025
Q2
$541K Hold
47,262
﹤0.01% 1533
2025
Q1
$639K Hold
47,262
﹤0.01% 1472
2024
Q4
$799K Hold
47,262
﹤0.01% 1453
2024
Q3
$960K Hold
47,262
﹤0.01% 1343
2024
Q2
$1.07M Hold
47,262
﹤0.01% 1236
2024
Q1
$1.24M Sell
47,262
-43,209
-48% -$1.23M ﹤0.01% 1178
2023
Q4
$2.85M Buy
90,471
+6,827
+8% +$185K 0.01% 777
2023
Q3
$2.35M Buy
83,644
+40,198
+93% +$1.38M 0.01% 784
2023
Q2
$1.6M Sell
43,446
-41,935
-49% -$1.28M ﹤0.01% 959
2023
Q1
$2.56M Buy
85,381
+11,987
+16% +$395K 0.01% 746
2022
Q4
$2.25M Buy
73,394
+20,058
+38% +$602K 0.01% 764
2022
Q3
$1.31M Buy
53,336
+2,230
+4% +$73.6K ﹤0.01% 941
2022
Q2
$1.64M Sell
51,106
-35,435
-41% -$1.3M ﹤0.01% 885
2022
Q1
$2.72M Buy
86,541
+28,845
+50% +$902K 0.01% 766
2021
Q4
$1.94M Sell
57,696
-82,460
-59% -$2.57M ﹤0.01% 971
2021
Q3
$4.07M Sell
140,156
-17,225
-11% -$558K 0.01% 739
2021
Q2
$5.48M Sell
157,381
-14,010
-8% -$464K 0.01% 617
2021
Q1
$4.78M Buy
171,391
+4,232
+3% +$113K 0.01% 636
2020
Q4
$4.14M Sell
167,159
-55,897
-25% -$1.33M 0.01% 679
2020
Q3
$4.66M Buy
223,056
+44,890
+25% +$866K 0.01% 651
2020
Q2
$2.73M Buy
178,166
+43,690
+32% +$552K 0.01% 809
2020
Q1
$1.19M Buy
134,476
+200
+0.1% +$2.88K ﹤0.01% 1095
2019
Q4
$2.43M Buy
+134,276
New +$2.23M 0.01% 970

Other funds holding CC

Ensign Peak Advisors's CC Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Chemours (CC) stake by 8.8% in Q2 2026, selling an estimated $22.9K and leaving 10,362 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Ensign Peak Advisors first reported a position in CC in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.48M in Q2 2021. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Ensign Peak Advisors held 10,362 shares of Chemours worth $213K as of Q2 2026.
  • Ensign Peak Advisors sold 1,000 Chemours shares in Q2 2026, an estimated $22.9K.
  • Chemours made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1356 holding.
  • Ensign Peak Advisors first reported a position in Chemours in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Chemours position peaked at $5.48M in Q2 2021.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.